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Abstract: The rational design of high-performance fluorescent materials for cancer targeting in vivo is 
still challenging. Here we report the unique molecular design strategy by tailoring aggregation-induced 
emission (AIE)-active organic molecules to realize preferable far-red and NIR fluorescence, well-
controlled morphology from rod-like to spherical, as well as tumor targeted bioimaging. The shape-
tailored organic quinoline-malononitrile (QM) nanoprobes are biocompatible, and highly desirable for 
cell tracking applications. Impressively, the spherical shape of QM-5 nanoaggregates exhibits excellent 
tumor-targeted bioimaging performance after intravenously injection into mice, but not the rod-like 
aggregates of QM-2. 
 
The development of bioimaging probes that can differentiate tumors from normal tissues are highly 
desirable for cancer diagnosis and therapy in vivo.[1,2] Fluorescent materials that provide dynamic and 
quantitative information of imaging biomolecules have become indispensable tools for biological analysis 
and clinical diagnosis.[3,4] In particular, organic nanomaterials with excellent synthetic flexibility for 
chemical modification are advantageous for real-time cell visualizations, diagnosis and treatment of 
diseases in vivo.[5] While nanomaterial bioimaging displays a critical interdependent role of particle shape, 
size and surface chemistry (such as polymers, liposomes, dendrimers, immunoconjugates, carbon 
nanotubes, porphysomes and inorganic particles),[6] methods to rationally tailor small molecules to afford 
organic nanostructures with the desired morphology, and therefore performing ideal function in diagnosis 
or therapy in vivo is less understood. 
Several impressive photo-electronic materials with well-defined morphologies can be obtained using 
tailor-made small molecules,[7] but these functional self-assemble materials remain further exploration on 
biomedical application, mainly due to several limitations: i) inherent fluorescence quenching which is 
common for most organic fluorophores during their aggregation in aqueous media; ii) lacking high-
performance near-infrared (NIR) emission; and iii) the unclear relationship between tailored 
morphologies and targeting efficacy for in vivo diagnostics. Fortunately, since the concept of aggregation-
induced emission (AIE) was originally reported by Tang et al,[8a] AIE-active molecules exhibit highly 
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bright fluorescence when aggregated, and weak fluorescence when separated in solution,[8] making them 
ideal for biosensing and imaging in vivo. However, mapping the nature of AIE-active organic molecules 
to finely control the morphologies and sizes of organic aggregated nanostructures is uncharted territory, 
especially the influence of substituents on the shape, and therefore the excellent optical properties for 
bioimaging in vivo. 
As well known, far-red and NIR emission could minimize photo-damage to living cells, enable deep 
tissue penetration, and circumvent the spectral overlap with biosubstrate autofluorescence.[9] While great 
efforts have been made towards the development of high-performance AIE-active systems for long-term 
non-invasive bioimaging in vivo,[8b] the majority of AIE luminogens has emission wavelengths below 650 
nm. Particularly, it is not clear whether AIE nanoaggregates with specific morphologies are suitable for 
targeted imaging in vivo. Herein we set out to construct a tailor-made far-red and NIR AIE-active system 
(Figure 1A) employing the quinoline-malononitrile (QM) as AIE building block[8f], wherein the 
morphology of organic nanostructures could be controlled by changing the electron donor groups and 
thiophene π-bridge. Different shapes of these AIE-active QM derivatives with red to NIR emission were 
carefully evaluated under an aggregated microenvironment, thus taking insight into the effect of specific 
shape on both real-time cell tracing and tumor-targeted imaging in vivo. 
We performed a series of experiments to examine the photoluminescence properties of QM derivatives. 
As expected, all QM compounds exhibit red to NIR AIE-active characteristics along with an increasing 
volume fraction of water in tetrahydrofuran/water (THF/H2O) mixtures (Figure 1, Figure S1 and Table S1 
in the Supporting Information). Moreover, their fluorescent properties are dependent upon the aggregated 
microenvironment. Specifically for QM-1, a strong fluorescence was not observed until the volume 
fraction of water (fw) in THF/H2O solutions up to 80% (Figure 1B). Its fluorescence quantum yield (ФF) 
exhibited AIE light-up enhancement by 178-fold in the mixed fw = 90% THF/H2O solution compared 
with that in pure THF solution. 
When strong donor groups are introduced into the thiophene moiety elongating the π-conjugated 
systems of the QM molecules, their emission spectra are extended to deep red, and even to the NIR region. 
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As shown in Figure 1C, with a gradual addition of water into THF, QM-2 molecules containing the 
triphenylamine donor clustered into nanoaggregates and the emission was dramatically enhanced with an 
fw increase, showing an obvious AIE effect. Successively, the emission spectra showed a little decrease 
when fw > 80%, which might be attributed that QM-2 molecules aggregate and precipitate quickly at 
higher water fraction, leading to amorphous agglomerates formation with lower fluorescence intensity.[10] 
Moreover, the fluorescence quantum yield (ФF) of QM-2 was increased sharply by about 183-fold from 
pure THF solution to the mixed THF/H2O (fw = 70%) solution. Furthermore, when a stronger 
alkoxytriphenylamine donor moiety was introduced into QM-3, the emission peak located at 672 nm in 
pure THF was observed in its molecularly dissolved state. When water was mixed with THF (fw > 50%), 
its emission spectra was bathochromically shifted to 705 nm with intensiﬁed AIE-active emission. 
 To further take insight into the substituent influence, a 3,4-ethylene-dioxythiophene (EDOT) unit was 
introduced into QM-2 to give QM-4, in which the steric hindrance of EDOT can change the initial D-π-A 
structure into more twist structure. In fact, the structural and conformational differences of QM 
derivatives are responsible for the different aggregated microenvironment, thus resulting in different AIE-
active spectral features. As demonstrated by the X-ray diffraction (XRD) patterns (Figure S2 in SI), QM-
4 aggregates are mainly in amorphous state, which might affect its fluorescent quantum yield.[10] Indeed, 
QM-4 exhibited 17-fold enhancement in ФF value from fw = 0 to 70% in a mixed THF/H2O solution, and 
concomitantly the emission peak was red-shifted from 642 to 669 nm (Figure 1D).  
Following this line of thought, a combinational molecular strategy was employed in the design of QM-
5, wherein the alkoxy-substituted triphenylamine moiety as a stronger donor would extend the NIR 
emission spectra, and EDOT-substituted thiophene would disrupt the linear D-π-A structure for tailoring 
the aggregate formation. Similar to QM-4, with an increase in water fraction, the emission spectra of QM-
5 exhibited a large red shift from 668 nm in pure THF solution to 721 nm in fw = 90% of the mixed 
THF/H2O solution (Figure 1E). To further verify our molecular design strategy, QM-6 was designed and 
synthesized, which also endowed similar AIE-active fluorescence properties. As a consequence, we are 
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able to extend the long wavelength AIE-active luminescence of QM derivatives from 612 to 721 nm in 
THF/H2O solution (Figure 1F), and even from 651 to 738 nm in their solid state (Figure 1G). 
 
[Figure 1] 
 
In order to explore the influence of substituents on the nanostructures, we employed a solution 
evaporation approach to fabricate QM aggregates. Indeed, the progressive transformation of morphology 
for QM aggregates were successfully observed, characterized with transmission electron microscopy 
(TEM), scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM). As 
shown in Figure 2A-I, the aggregates of QM-1, QM-2 and QM-3 were well-defined microrods with 
different sizes and diameters. For instance, the uniform 1-D microrods of QM-2 were observed by SEM 
with the size of about 10 μm in length and 0.5-1 μm in diameter (Figure 2E). The TEM and CLSM 
images in Figures 2D and 2F further verified rod-like microstructures in the aggregates of QM-2. Similar 
morphological characteristics could also be observed in QM-1 and QM-3 aggregates, demonstrating 
strong AIE-active fluorescence and easily linear self-aggregation when thiophene was utilized as a π-
conjugated bridge in the QM derivatives. Fortunately, the single crystals of QM-1, QM-2 and QM-3 were 
obtained by the slow evaporation approach (Table S2 and Figure S3 in SI). All QM-1, QM-2 and QM-3 
display twisted conformations in their crystal structures with large torsional angles of 85.4~87.0º between 
the N-ethyl and the quinoline units (Figure 1A). In addition, moderate interplanar angles of 32.2~35.3º are 
observed between the ethylene and quinoline units, and no obvious π-π stacking interactions can be found 
in the crystals, which may be ascribed to the twisted molecular structures. As a result, their aggregation 
states display enhanced emission.  
However, for QM-4, QM-5 and QM-6 (Figure 2J-R), instead of the microrod structures, the resulting 
morphology was predominated with spherical shaped nanoparticles in diameter of about 80-200 nm. This 
might be ascribed to the attachment of an epoxyethyl group in the EDOT π-bridge, leading to a totally 
different intermolecular interaction in the aggregation state. Moreover, the average diameters of QM-5 
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aggregates measured by laser light scattering (LLS) were about 85 (±10) nm, exactly in consistent with 
the data from SEM images (90±10 nm). Under the same fabricating conditions, the TEM images of QM-5 
had the smallest diameters and smoothest spherical morphologies with respect to QM-4 and QM-6 
(Figure S4 in SI). 
Based on the rational molecular design, the flexibility and electron rich properties of the epoxy ethyl 
groups in QM chemical structures play important roles in the morphological formation during the 
aggregation process when EDOT is introduced as the π-conjugated bridge. It is expected that the 
incorporation of both alkoxytriphenylamine group and EDOT unit in QM derivatives is a preferable 
design strategy to generate AIE-active spherical nanostructures, resulting in a distinct change in 
morphology from QM-1 to QM-6 (Figure 2). 
 
[Figure 2] 
 
Considering nanoprobes for bioimaging in vivo, it is necessary to assess the external influence on 
aggregation and photostability of AIE materials. As shown in Figure S5-6 in SI, once QM derivatives 
have formed into aggregation state under the optimized fw, external factors have little effect on the 
morphology of QM aggregates. Also the photostability of AIE-active QM materials and commercial ICG 
dye (approved by FDA for NIR clinical imaging agents) was evaluated by time-course fluorescence 
measurement. After exposure to high density light, the half-life time of QM derivatives was about 20-fold 
longer than ICG dye, demonstrating that QM derivatives are more photostable materials. 
Among all the QM derivatives, QM-2 and QM-5 are the typical representatives of rod-like and 
spherical shapes, respectively. Thus, we chose these two compounds to further explore their potential 
shape effects on in vitro and in vivo applications in living system.  Exactly, QM-2 and QM-5 exhibited 
low toxicity against both cancer cells and normal cells, highly preferable for cell imaging or tracking 
applications (Figures S7-S10 in SI). Flow cytometric studies were conducted to evaluate the kinetics of 
the cell uptake process of QM-2 and QM-5 in the Hela cells. Although the relative uptake ratio of both 
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compounds after 48 h incubation was close to 100% (≥ 99.5%), the initial uptake rate of QM-5 was much 
faster compared to that of QM-2. Additionally, the CLSM images presented a direct observation of the 
spherical shape of QM-5 in cells. 
The high-brightness emission for AIE-active organic nanomaterials could be used as efﬁcient long-
term cell tracers. For instance, QM-2, QM-5 and commercial ICG dye as control showed bright 
fluorescence after incubation with Hela cells for 24 h in spite of the different retention in the cytoplasm of 
Hela cells (with the potential as long-term cell tracers). For QM-2 and QM-5, even after four passages of 
incubation with living cells, the fluorescence of QM aggregates staining in Hela cells was still emissive. 
In contrast, there was almost no fluorescence signal using ICG at two passages of incubation. Therefore, 
the formation of high biocompatible and photostable AIE-active QM aggregates with different shape and 
size is beneficial to retain fluorescence in the cells, desirable for long term cell tracing. 
The promising long-term cell tracing results of AIE-active QM derivatives inspired us to further 
explore their feasibility as NIR bioprobes in vivo. Upon intravenous injection of QM-2 at a dose of 0.15 
mg/kg, we immediately monitored the fluorescence distribution in mice at different periods of time. As 
shown in Figure 3A, the fluorescence was clearly observed in mice at 30 min, indicative of the rapid 
distribution of QM-2 aggregates via the blood circulation. Surprisingly, upon the paralleled intravenous 
injection of QM-5 (0.15 mg/kg, Figure 3B), the distinct NIR fluorescence could predominately be 
detected in the tumor at 30 min, rather than other organs of the mouse, and retained in tumor tissue even 
at 24 h after injection. The long retention of the QM-5 nanoaggreates in tumors makes this system very 
promising for tumor labeling and chemotherapy. However, even at 24 h after the injection, the QM-2 
aggregates were still present in the whole mouse body biodistribution without producing tumor-targeted 
fluorescence signals in vivo. Similar phenomenon was also observed for another rod-like nanostructure 
QM-3 (Figure S11 in SI), further confirming the non-specific in vivo imaging biodistribution of organic 
rod-like QM assemblies. 
The ex vivo fluorescence images of the internal organs of mice sacrificed at 24 h post-injection in 
Figure 3D also indicated that QM-5 aggregates accumulated in the tumor and liver tissue, whereas the 
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fluorescence of QM-2 aggregates in tumor was much weaker than other organs such as liver or lung 
(Figure 3C). Furthermore, the 3D fluorescence imaging of tumor-bearing mice in Figure 3E at 24 h post-
injection of QM-5 (0.15 mg/kg) further confirmed the NIR fluorescence accumulation in tumors. 
Accordingly, the semi-quantitative analysis data of the average fluorescence intensity distribution in 
organs (Figure 3F) also demonstrated that the spherical shape of QM-5 aggregates exhibited much higher 
tumor-targeting ability than the rod-like aggregates of QM-2.  
Undoubtedly, in contrast with the fast degradation in aqueous media and quick clearance from the body 
of small molecular imaging agent ICG dye[11] (control, Figure S12 in SI), the shape-specificity of QM 
aggregates contributes a direct benefit for long-term retention and bioimaging in vivo. Actually, from the 
TEM images of cells and tissues, we clearly observed that QM aggregates almost maintained their initial 
aggregated morphologies in situ (Figure S13 in SI). While the fluorescence of rod-like aggregates by 
QM-2 exhibited the whole body biodistribution in mice, the spherical QM-5 aggregates enhanced tumor-
targeting capacity, which could be ascribed to the “passive” tumor-targeting by enhanced permeability 
and retention (EPR) effect.[12] Apparently, here the particle geometry plays an important role in the 
tumor-targeted bioimaging in vivo. Another potential possibility for this disparity could be the difference 
in shape and shape-related factors such as curvature and aspect ratio, which affect cell-particle 
interactions, particle transport characteristics and margination dynamics.[6k,12] Therefore, based on the 
TEM images of Hela cells and tissues, the shape differences of QM aggregates formed by tailoring AIE-
active organic molecules are of great value for tumor-targeted bioimaging in vivo. 
 
[Figure 3] 
 
In summary, far-red and NIR AIE-active fluorescent organic QM nanoprobes have been rationally 
designed. We specifically focused on the modulation of long emitting wavelength and the aggregated 
morphologies via essentially tailoring π-bridge and donor unit in molecular structures. QM derivatives 
from rod-like to spherical morphology were well confirmed by SEM, TEM and CLSM images. In vitro 
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experiments have verified that these tailor-made long wavelength AIE-active organic QM nanomaterials 
are biocompatible and retained in the cytoplasm of living cells. The most striking feature of NIR spherical 
QM-5 nanoaggregates is their excellent tumor-targeting performance in mice. Conversely, the same is not 
true for the rod-like aggregates of QM-2 which does not display any tumor targeting properties. To the 
best of our knowledge, this is the first report of shape-specific tumor targeting using bare NIR AIE-active 
nanoprobes. Our strategy generates high-performance long wavelength AIE-active organic nanomaterials 
with ideal biological geometries for tumor-targeted bioimaging in vivo, providing a promising platform 
for in situ and in vivo tumor imaging agents.  
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Legends for Figures and Schemes and Tables 
 
Figure 1. QM derivatives and AIE properties: (A) Molecular structures and the single crystal 
configurations of QM-1, QM-2 and QM-3. Photoluminescence spectra and plot of the relative PL 
intensity of QM derivatives (10-5 M): (B) QM-1, (C) QM-2, (D) QM-4 and (E) QM-5 in THF/H2O 
mixtures with different volume fractions of water (fw); λex = 480 nm. Inset: Fluorescent photoimages in 
pure THF solvent and THF/H2O solution of (B) QM-1 (fw = 90%), (C) QM-2 (fw = 70%), (D) QM-4 (fw = 
70%) and (E) QM-5 (fw = 90%) under 365 nm illumination. (F) Normalized fluorescent spectra of QM-1 
(fw = 90%), QM-2 (fw = 70%), QM-3 (fw = 90%), QM-4 (fw = 70%), QM-5 (fw = 90%) and QM-6 (fw = 
90%) in THF/H2O solution. (G) Normalized fluorescent spectra of QM derivatives in the solid state. 
 
Figure 2. Multiple morphologies of micro/nanoaggregates fabricated from QM derivatives (10-5 M). 
TEM, SEM and confocal laser scanning microscope (CLSM) images recorded for the 
micro/nanoaggregates of QM-1 (A-C), QM-2 (D-F), QM-3 (G-I), QM-4 (J-L), QM-5 (M-O) and QM-6 
(P-R), prepared by adding different content of water into pure THF solution to afford the mixed solution 
of THF/H2O then still standing for 1 h. 
 
Figure 3. In vivo non-invasive imaging of tumor-bearing mice after intravenous injection of (A) QM-2 
(0.15 mg/kg), (B) QM-5 (0.15 mg/kg) at different periods of time (0.5, 1.5, 3 and 24 h), and ex vivo 
fluorescence images of the internal organs of mice sacrificed at 24 h post-injection with (C) QM-2 and 
(D) QM-5. (E) The 3D fluorescence imaging of tumor-bearing mice after intravenous injection of QM-5 
(0.15 mg/kg) for 24 h. (F) Average fluorescence intensity distribution for tumor and internal organs from 
mice sacrificed at 24 h post-injection with QM-2 and QM-5 (n = 3). 
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Figure 3. In vivo non-invasive imaging of tumor-bearing mice after intravenous injection of (A) QM-2 
(0.15 mg/kg), (B) QM-5 (0.15 mg/kg) at different periods of time (0.5, 1.5, 3 and 24 h), and ex vivo 
fluorescence images of the internal organs of mice sacrificed at 24 h post-injection with (C) QM-2 and 
(D) QM-5. (E) The 3D fluorescence imaging of tumor-bearing mice after intravenous injection of QM-5 
(0.15 mg/kg) for 24 h. (F) Average fluorescence intensity distribution for tumor and internal organs from 
mice sacrificed at 24 h post-injection with QM-2 and QM-5 (n=3). 
 
 
